Esperion Therapeutics reported $75K in Ordinary Share Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.24M 10K
Amarin AMRN:US USD 298.6M 3.94M
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Cytokinetics CYTK:US USD 94K 1000
Daiichi Sankyo 4568:JP JPY 50B 0
Esperion Therapeutics ESPR:US USD 75K 3K
Geron GERN:US USD 390K 8K
Halozyme Therapeutics HALO:US USD 135K 0
Heron Therapeutics HRTX:US USD 1.19M 3K
Intercept Pharmaceuticals ICPT:US USD 42K 1000
Intra Cellular Therapies ITCI:US USD 9K 0
Minerva Neurosciences NERV:US USD 1000 0
Moderna Inc MRNA:US USD 38.5K 200
Nektar Therapeutics NKTR:US USD 19K 0
Ptc Therapeutics PTCT:US USD 72K 1000
Puma Biotechnology PBYI:US USD 5K 0
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 187K 2K
United Therapeutics UTHR:US USD 700K 0
Vanda Pharmaceuticals VNDA:US USD 57K 0